Global Fish Vaccine Market Growth 2023-2029

Global Fish Vaccine Market Growth 2023-2029

Fish vaccine are vaccine specially used on fish. The culture environment, be it in tanks, cages or ponds, seawater or freshwater, can stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed animals, have an increased susceptibility to infectious diseases. Such diseases may be bacterial, viral, fungal or parasitic in origin. These are the immune foundations for immunizing fish against various diseases.
LPI (LP Information)' newest research report, the “Fish Vaccine Industry Forecast” looks at past sales and reviews total world Fish Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Fish Vaccine sales for 2023 through 2029. With Fish Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fish Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Fish Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fish Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Fish Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fish Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fish Vaccine.
The global Fish Vaccine market size is projected to grow from US$ 331.2 million in 2022 to US$ 627 million in 2029; it is expected to grow at a CAGR of 627 from 2023 to 2029.
The industry's leading producers are Zoetis and Merck & Co., Inc., which accounted for 52.92% and 34.85% of revenue in 2019, respectively.
This report presents a comprehensive overview, market shares, and growth opportunities of Fish Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Injectable Vaccines
Dip Vaccines
Oral Vaccine
Segmentation by application
Pangasius
Tilapia
Salmon
Seabass
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Merck & Co., Inc.
Tecnovax
Veterquimica S.A.
HIPRA
Anicon Labor GmbH
Key Questions Addressed in this Report
What is the 10-year outlook for the global Fish Vaccine market?
What factors are driving Fish Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fish Vaccine market opportunities vary by end market size?
How does Fish Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.